These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2397940)

  • 1. Lymphocyte arginase activity in leprosy--a preliminary report.
    Babu CS; Kannan KB; Bharadwaj VP; Katoch VM
    Indian J Med Res; 1990 May; 91():193-6. PubMed ID: 2397940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients.
    Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase activity in leprosy (a preliminary study).
    Chaudhary SD; Gupta V; Saini AS; Singh V; Lal H
    Indian J Lepr; 1988 Jan; 60(1):17-20. PubMed ID: 3204272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
    Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine deaminase activity in leprosy.
    Shende RK; Bardapurker J; Patil V; Gaikwad A
    Indian J Lepr; 1993; 65(2):201-5. PubMed ID: 8345233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine deaminase activity in leprosy.
    Suri Babu SS; Kannan KB; Katoch VM; Bharadwaj VP
    Indian J Lepr; 1990; 62(4):473-7. PubMed ID: 2086683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme immunoassay of phagocytosis stimulating tetrapeptide "tuftsin" in normal and leprosy sera.
    Kaur J; Khare S; Bhutani LK; Rao DN
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):576-81. PubMed ID: 1802940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum enzyme profile in leprosy patients.
    Singh NB; Chaudhary MS
    Indian J Lepr; 1988 Jul; 60(3):374-9. PubMed ID: 3198957
    [No Abstract]   [Full Text] [Related]  

  • 11. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte glutathione peroxidase, glutathione reductase activities and blood glutathione content in leprosy.
    Prasad CV; Kodliwadmath MV; Kodliwadmath GB
    J Infect; 2008 Jun; 56(6):469-73. PubMed ID: 18440071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
    Goulart IM; Mineo JR; Foss NT
    Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of antibodies to 35 kD determinant of M. leprae in urine and serum of leprosy patients.
    Patil S; Dwivedi P; Kiran K; Singh K; Sengupta U
    Acta Leprol; 1990; 7(2):139-43. PubMed ID: 1699385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of serum lipids and lipoproteins in leprosy.
    Ahaley SK; Sardeshmukh AS; Suryakar AN; Samson PD
    Indian J Lepr; 1992; 64(1):91-8. PubMed ID: 1573306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and histopathological correlation in the classification of leprosy.
    Bhatia AS; Katoch K; Narayanan RB; Ramu G; Mukherjee A; Lavania RK
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):433-8. PubMed ID: 8228443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatoglyphics in leprosy: (III) Creases of palm.
    Ghei SK; Katoch K; Girdhar BK; Ramu G; Sengupta U
    Indian J Lepr; 1989 Jan; 61(1):96-102. PubMed ID: 2703748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of serum zinc level in leprosy.
    Saxena N; Sharma RP; Singh VS
    Indian J Lepr; 1988 Oct; 60(4):556-61. PubMed ID: 3253334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.